Wang Bin, Cai Jin, Huang Longtao, Chen Yonghao, Wang Ruoxi, Luo Mengyao, Yang Meng, Zhang Mohan, Chen Guangying, Huang Guolei, Zheng Caijuan
Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou, China.
Key Laboratory of Tropical Medicinal Plant Chemistry of Hainan Province, Haikou, China.
Front Microbiol. 2024 Sep 19;15:1464135. doi: 10.3389/fmicb.2024.1464135. eCollection 2024.
Bacterial infections pose a significant clinical burden on global health. The growing incidence of drug-resistant pathogens highlights the critical necessity to identify and isolate bioactive compounds from marine resources. Marine-derived fungi could provide novel lead compounds against pathogenic bacteria. Due to the particularity of the marine environment, species derived from marine sources have proven to be potent producers of bioactive secondary metabolites and have played a considerable role in advancing drug development. This study reviews the structural diversity and activities against pathogenic bacteria of secondary metabolites isolated from marine-derived species over the past 14 years (January 2010-June 2024), and 337 natural products (including 145 new compounds) were described. The structures were divided into five major categories-terpenoids, nitrogen-containing compounds, polyketides, steroids, and other classes. These antimicrobial metabolites will offer lead compounds to the development and innovation of antimicrobial agents.
细菌感染给全球健康带来了重大的临床负担。耐药病原体发病率的不断上升凸显了从海洋资源中识别和分离生物活性化合物的迫切必要性。海洋来源的真菌可以提供对抗病原菌的新型先导化合物。由于海洋环境的特殊性,海洋来源的物种已被证明是生物活性次生代谢产物的有效生产者,并在推动药物开发方面发挥了重要作用。本研究综述了过去14年(2010年1月至2024年6月)从海洋来源物种中分离出的次生代谢产物的结构多样性及其对病原菌的活性,并描述了337种天然产物(包括145种新化合物)。这些结构分为五大类——萜类化合物、含氮化合物、聚酮化合物、甾体化合物和其他类别。这些抗菌代谢产物将为抗菌药物的开发和创新提供先导化合物。